Medical Science Liaison, South-West Germany

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC‑9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity We are seeking a highly motivated and experienced professional to join our team as a Medical Science Liaison. The incumbent will execute approved field medical plans within an assigned territory in Germany, engage in peer‑to‑peer scientific exchange with healthcare professionals that translate into medical insights, support clinical study site and investigator engagement, and contribute to medical education, advisory boards and medical congress activities under the direction of the Senior Director, Medical Affairs, Germany. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. The individual will collaborate with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail‑oriented, proactive, and a skilled collaborator. The MSL is an individual contributor role with no direct line‑management responsibilities. They contribute to field insights and scientific expertise to support the German medical plan but does not own country medical strategy, governance, budget, or team leadership. Key Responsibilities Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge. Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions. Collect, document, synthesize, and communicate field medical insights from KOLs and HCPs to the Medical Director and relevant internal teams. Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities. Establish credibility as a scientific expert and resource for internal stakeholders, providing medical and scientific support for products and therapeutic areas. Collaborate cross‑functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics. Stay current with scientific literature, emerging research, and competitive landscape. Adhere to Revolution Medicines Core Values and policies. Understand the regulatory requirements for customer engagement by field‑based employees. Execute the approved German field medical engagement plan for assigned accounts and stakeholders. Maintain high‑quality documentation of scientific interactions and insights in accordance with company systems and compliance requirements. Support onboarding and informal coaching of new field medical colleagues, where appropriate. Provide territory‑level input to medical planning, launch readiness, and external engagement priorities. Required Skills, Experience and Education Doctoral degree in scientific or medical discipline. 8+ years of relevant experience in Medical Affairs, Field Medical, Clinical Development, or a similar role within the pharmaceutical or biotech industry; prior MSL experience in Germany strongly preferred. Strong understanding of clinical research methodologies and drug development processes. Knowledge and experience within the oncology therapeutic area, prior experience in lung and gastrointestinal cancers is preferred. Excellent verbal and written communication skills. Proven ability to analyze and synthesize scientific information effectively. Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences. Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals. Self‑directed and able to thrive in a fast‑paced and dynamic environment. Willingness to travel up to 60% of time. Preferred Skills Preferred experience in lung and gastrointestinal cancers. Experience with both early and late‑stage clinical assets as well as approved therapies. Strong analytical and communication skills. Outstanding written, verbal, and interpersonal communication skills, a structured approach to tasks and a professional appearance is essential to embody the core values from Revolution Medicines. Flexible team member who can handle ambiguity and evolving priorities in a fast‑growing organization embracing a positive attitude towards change, able to operate within agreed financial budgets. Ability to set priorities and work towards tight timelines with a willingness to travel, mainly within Germany. #J-18808-Ljbffr Revolution Medicines